> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Aratana Therapeutics NADA for Post-op Analgesic
- URL: https://www.fdaweb.com/aratana-therapeutics-nada-for-post-op-analgesic/
- Published: 2016-06-30T12:00:00.000Z
- Updated: 2026-09-14T21:12:39.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5136096

Aratana Therapeutics has submitted a new animal drug application for Nocita (bupivacaine liposome injectable suspension), indicated as a local post-operative analgesic for cranial cruciate ligament surgery in dogs. The user fee review target date is 8/28\. The company says the drug “lasts up to 72 hours post-surgery by releasing bupivacaine over time from multi-vesicular liposomes deposited in the tissue.” It is administered as a single dose by tissue infiltration during closure of cranial cruciate ligament surgery in dogs.